Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China · Delayed Price · Currency is CNY 19.36
-0.30 (-1.53%)
May 20, 2026, 1:55 PM CST
SHA:600513 Revenue
Jiangsu Lianhuan Pharmaceutical had revenue of 810.63M CNY in the quarter ending March 31, 2026, with 29.14% growth. This brings the company's revenue in the last twelve months to 2.89B, up 28.10% year-over-year. In the year 2025, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.71B with 25.52% growth.
Revenue (ttm)
2.89B
Revenue Growth
+28.10%
P/S Ratio
1.94
Revenue / Employee
1.36M
Employees
1,388
Market Cap
5.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.71B | 551.40M | 25.52% |
| Dec 31, 2024 | 2.16B | -13.64M | -0.63% |
| Dec 31, 2023 | 2.17B | 218.94M | 11.20% |
| Dec 31, 2022 | 1.96B | 309.34M | 18.80% |
| Dec 31, 2021 | 1.65B | 259.78M | 18.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition